Engineered dendritic cells boost cancer immunotherapy

EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work, covered in two papers, turns the previously lab-based method into a full-blown immunotherapy strategy.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup